10 Questions
Administration of cis-retinoic acid is a type of immunotherapy for neuroblastoma.
False
Immunotherapy is used to eliminate residual disease after chemotherapy for neuroblastoma.
True
Stage IV neuroblastoma has a low rate of spontaneous regression.
False
Neuroblastoma has a 5-year survival rate of 50% in children.
False
Recurrent disease is rare in children with neuroblastoma.
False
The prognosis is worse in children diagnosed before 1 year of age.
False
There are no known risk factors associated with osteosarcoma development.
False
Retinoblastoma is not linked to an elevated risk of osteosarcoma development.
False
Fibrous dysplasia is not a risk factor for osteosarcoma.
False
Hereditary multiple exostoses is not a risk factor for osteosarcoma.
False
This quiz assesses your knowledge of the administration and side effects of chemotherapy in children, including the use of central venous catheters and the complications that can arise from treatment. Topics covered include the effects of chemotherapy on blood cell count and uric acid levels.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
